Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Amortizatization of Intangibles (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Amortizatization of Intangibles for 6 consecutive years, with -$3000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 106.38% to -$3000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $78000.0, a 22.77% decrease, with the full-year FY2024 number at $129000.0, up 10.26% from a year prior.
  • Amortizatization of Intangibles was -$3000.0 for Q3 2025 at Plus Therapeutics, up from -$13000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $59000.0 in Q4 2024 to a low of -$13000.0 in Q2 2025.
  • A 4-year average of $23866.7 and a median of $28000.0 in 2022 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: surged 115.38% in 2023, then plummeted 128.57% in 2024.
  • Plus Therapeutics' Amortizatization of Intangibles stood at $27000.0 in 2022, then increased by 14.81% to $31000.0 in 2023, then skyrocketed by 90.32% to $59000.0 in 2024, then crashed by 105.08% to -$3000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Amortizatization of Intangibles are -$3000.0 (Q3 2025), -$13000.0 (Q2 2025), and $35000.0 (Q1 2025).